Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HPGD | P15428 | 7/20 | 1.00 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 1.00 |
| ▸ | TSHR | P16473 | 4/20 | 0.68 |
| ▸ | POLB | P06746 | 2/20 | 0.63 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.63 |
| ▸ | CTDSP1 | Q9GZU7 | 1/20 | 0.63 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.63 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.63 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.63 |
| ▸ | MAPT | P10636 | 3/20 | 0.59 |
| ▸ | LMNA | P02545 | 3/20 | 0.59 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.59 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.59 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.59 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.59 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.59 |
| ▸ | NPC1 | O15118 | 2/20 | 0.59 |
| ▸ | RAB9A | P51151 | 2/20 | 0.59 |
| ▸ | RECQL | P46063 | 1/20 | 0.59 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2221037 | 1.00 | HPGD (1.00) | HPGDALDH1A1TSHRPOLBTDP1 | |
| SCHEMBL7143238 | 0.82 | HPGD (0.69) | HPGDALDH1A1TSHRPOLBTDP1 | |
| SCHEMBL2219521 | 0.80 | HPGD (0.66) | HPGDALDH1A1TSHRPOLBTDP1 | |
| SCHEMBL1155738 | 0.78 | HPGD (1.00) | HPGDALDH1A1TSHRL3MBTL1MAPK1 | |
| SCHEMBL7856948 | 0.78 | HPGD (1.00) | HPGDALDH1A1TSHRL3MBTL1MAPK1 | |
| SCHEMBL23680002 | 0.78 | HPGD (1.00) | HPGDALDH1A1TSHRL3MBTL1MAPK1 | |
| SCHEMBL2185561 | 0.77 | HPGD (0.62) | HPGDALDH1A1TSHRPOLBTDP1 | |
| SCHEMBL8162150 | 0.77 | MAPT (0.76) | HPGDALDH1A1TSHRPOLBTDP1 | |
| SCHEMBL8162146 | 0.77 | MAPT (0.76) | HPGDALDH1A1TSHRPOLBTDP1 | |
| SCHEMBL4323081 | 0.76 | HPGD (0.61) | HPGDALDH1A1TSHRPOLBTDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2216312-B1 | PROCESS FOR PRODUCING ORGANIC COMPOUND | M TECHNIQUE CO LTD (JP) | 2019-05-01 | — | — | EP | disclosed |
| US-8592498-B2 | Method for producing organic compound and organic compound obtained by the method | M. TECHNIQUE CO., LTD. (JP) | 2013-11-26 | — | — | US | disclosed |
| US-20110178199-A1 | METHOD FOR PRODUCING ORGANIC COMPOUND AND ORGANIC COMPOUND OBTAINED BY THE METHOD | M. TECHNIQUE CO., LTD. (JP) | 2011-07-21 | — | — | US | disclosed |
| EP-2216312-A1 | PROCESS FOR PRODUCING ORGANIC COMPOUND AND ORGANIC COMPOUND OBTAINED BY THE SAME | M Technique Co., Ltd. (JP) | 2010-08-11 | — | — | EP | disclosed |
| US-7009059-B2 | Method for the 1,3 dipolar cycloaddition of organic compounds in a microreactor | MERCK PATENT GMBH (DE) | 2006-03-07 | — | — | US | disclosed |
| US-20030163001-A1 | Method for oximating organic carbonyl compounds and/or ch-acid compounds | WURZIGER HANNS (DE) | 2003-08-28 | — | — | US | disclosed |
| US-20030158421-A1 | Method for the 1,3 dipolar cycloaddition of organic compounds in a microreactor | MERCK PATENT GMBH (DE) | 2003-08-21 | — | — | US | disclosed |
| EP-1268485-A1 | METHOD FOR THE 1,3 DIPOLAR CYCLOADDITION OF ORGANIC COMPOUNDS IN A MICROREACTOR | MERCK PATENT GmbH (DE) | 2003-01-02 | — | — | EP | disclosed |
| EP-1268406-A1 | METHOD FOR OXIMATING ORGANIC CARBONYL COMPOUNDS AND/OR CH-ACID COMPOUNDS | MERCK PATENT GmbH (DE) | 2003-01-02 | — | — | EP | disclosed |
| WO-2001074760-A1 | METHOD FOR OXIMATING ORGANIC CARBONYL COMPOUNDS AND/OR CH-ACID COMPOUNDS | MERCK PATENT GMBH (DE) | 2001-10-11 | — | — | WO | disclosed |
| WO-2001074822-A1 | METHOD FOR THE 1,3 DIPOLAR CYCLOADDITION OF ORGANIC COMPOUNDS IN A MICROREACTOR | MERCK PATENT GMBH (DE) | 2001-10-11 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110178199-A1 | METHOD FOR PRODUCING ORGANIC COMPOUND AND ORGANIC COMPOUND OBTAINED BY THE METHOD | OR10J3, PORCN, ABCG2 | HPGD 3527/4885ALDH1A1 3191/4885TSHR 3423/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.